Insulet Corporation announced that Shacey Petrovic has decided to step down from her position as President of Insulet for personal family reasons, effective June 1, 2022. Ms. Petrovic will continue to serve on the Company's Board of Directors. She will also serve as an advisor to the Company through May 2023 to support the leadership transition and Insulet's continued growth.

Effective June 1, 2022, Jim Hollingshead, Ph.D. will succeed Ms. Petrovic as Insulet's President. Dr. Hollingshead has served as an independent member of Insulet's Board of Directors since 2019, and is currently President of the Sleep and Respiratory Care business at ResMed Inc. Prior to joining ResMed in 2010, Dr. Hollingshead spent nearly two decades in strategy consulting across a range of industries including biotech, technology, and telecommunications. In addition to his role on the Insulet Board, he currently serves on the Board of SleepScore Labs.